Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy- pharmacotherapy combinations

Journal of Clinical Psychiatry

Volumn 73, Issue 4, 2012, Pages 478-485

  Troxel, Wendy M ^a   Kupfer, David J ^b   Reynolds III, Charles F ^b   Frank, Ellen ^a   Thase, Michael E ^c   Miewald, Jean M ^b   Buysse, Daniel J ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE;

ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; RISK FACTOR; SLEEP INDUCTION; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE;

EID: 84860572975     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07184     Document Type: Article

References (52)

1. Kupfer DJ, Frank E, McEachran AB, et al. Delta sleep ratio: a biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry. 1990;47(12):1100-1105. PubMed
2. Pigeon WR, Hegel M, Unutzer J, et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 2008;31(4):481-488. PubMed (Pubitemid 351694270)
3. Buysse DJ, Reynolds CF 3rd, Hoch CC, et al. Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients. Neuropsychopharmacology. 1996;14(4):243-252. doi:10.1016/0893-13X(95) 014-S PubMed
4. Kanai T, Takeuchi H, Furukawa TA, et al. Time to recurrence after recovery from major depressive episodes and its predictors. Psychol Med. 2003; 33(5):839-845. doi:10.1017/S0329170307827 PubMed (Pubitemid 36874663)
5. Karp JF, Buysse DJ, Houck PR, et al. Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment. Am J Psychiatry. 2004;161(10):1877-1884. doi:10.176/api.ajp.161.10.187 PubMed (Pubitemid 39314683)
6. Pigeon WR, May PE, Perlis ML, et al. The effect of interpersonal psychotherapy for depression on insomnia symptoms in a cohort of women with sexual abuse histories. J Trauma Stress. 2009;22(6):634-638. PubMed
7. Carney CE, Segal ZV, Edinger JD, et al. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry. 2007;68(2):254-260. doi:10.408/JCP.v68n021 PubMed (Pubitemid 46362647)
8. Buysse DJ, Reynolds CF 3rd, Houck PR, et al. Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy? J Clin Psychiatry. 1997;58(10):426-432. doi:10.408/JCP.v58n103 PubMed (Pubitemid 27485619)
9. Dew MA, Reynolds CF 3rd, Houck PR, et al. Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry. 1997;54(11):1016-1024. PubMed (Pubitemid 27476097)
10. Thase ME, Buysse DJ, Frank E, et al. Which depressed patients will respond to interpersonal psychotherapy? the role of abnormal EEG sleep profiles. Am J Psychiatry. 1997;154(4):502-509. PubMed (Pubitemid 27147603)
11. Thase ME. Depression, sleep, and antidepressants. J Clin Psychiatry. 1998;59(suppl 4):55-65. PubMed (Pubitemid 28169260)
12. Dombrovski AY, Cyranowski JM, Mulsant BH, et al. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? Depress Anxiety. 2008;25(12):1060-1066. doi:10.102/da.20467 PubMed
13. Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry. 2003;160(6):1147-1156. doi:10.176/api.ajp.160.6.147 PubMed (Pubitemid 41070975)
14. Perlis ML, Giles DE, Buysse DJ, et al. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 1997;42(2-3):209-212. doi:10.1016/S0165-0327(96)0141-5 PubMed (Pubitemid 27170166)
15. Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med. 2006;4(2):104-113. doi:10.1207/s15402010bsm04023 PubMed
16. Vgontzas AN, Liao D, Bixler EO, et al. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491-497. PubMed
17. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009;32(11):1980-1985. doi:10.237/dc09-0284 PubMed
18. Fernandez-Mendoza J, Calhoun S, Bixler EO, et al. Insomnia with objective short sleep duration is associated with deficits in neuropsychological performance: a general population study. Sleep. 2010;33(4):459-465. PubMed
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
20. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47(12):1093-1099. PubMed
21. Reynolds CF 3rd, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am J Psychiatry. 1992;149(12):1687-1692. PubMed
22. Simons AD, Thase ME. Biological markers, treatment outcome, and 1-year follow-up in endogenous depression: electroencephalographic sleep studies and response to cognitive therapy. J Consult Clin Psychol. 1992;60(3):392-401. PubMed doi:10.1037/02-06X.60.3.392
23. Nofzinger EA, Thase ME, Reynolds CF 3rd, et al. Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Arch Gen Psychiatry. 1993;50(1):24-30. PubMed (Pubitemid 23026985)
24. Buysse DJ, Kupfer DJ, Frank E, et al. Electroencephalographic sleep studies in depressed outpatients treated with interpersonal psychotherapy, 2: longitudinal studies at baseline and recovery. Psychiatry Res. 1992;42(1):27-40. doi:10.1016/0165-1781(92)9036-3 PubMed
25. Frank E, Kupfer DJ, Buysse DJ, et al. Randomized trial of weekly, twicemonthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. Am J Psychiatry. 2007;164(5):761-767. doi:10.176/api.ajp.164.5.761 PubMed (Pubitemid 46808531)
26. Klerman GL, Weissman MM, Rounsaville BJ, et al. Interpersonal Psychotherapy of Depression. New York, NY: Academic Press, Basic Books Inc; 1984.
27. Beck AT, Rush AJ, Shaw BF, et al. Cognitive Therapy of Depression: A Treatment Manual. New York, NY: Guilford Press; 1979.
28. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54(11):1009-1015. PubMed (Pubitemid 27476096)
29. Schmidt HS, Kaelbling R. The differential laboratory adaptation of sleep parameters. Biol Psychiatry. 1971;3(1):33-45. PubMed
30. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects NIH Publication 204. Washington, DC: US Government Printing Office, Department of Health Education and Welfare; 1968
31. Kupfer DJ, Ehlers CL, Frank E, et al. EEG sleep profiles and recurrent depression. Biol Psychiatry. 1991;30(7):641-655. doi:10.1016/06-323(91)9010-J PubMed
32. Buysse DJ, Ancoli-Israel S, Edinger JD, et al. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29(9):1155-1173. PubMed (Pubitemid 44484809)
33. Lichstein KL, Durrence HH, Taylor DJ, et al. Quantitative criteria for insomnia. Behav Res Ther. 2003;41(4):427-445. doi:10.1016/S05-7967(02)023-2 PubMed (Pubitemid 36315726)
34. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. doi:10.192/bjp.134.4.382 PubMed (Pubitemid 9136500)
35. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-855. PubMed
36. Andreescu C, Lenze EJ, Dew MA, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry. 2007;190(4):344-349. doi:10.192/bjp.bp.106.027169 PubMed (Pubitemid 46580685)
37. Fava M, Uebelacker LA, Alpert JE, et al. Major depressive subtypes and treatment response. Biol Psychiatry. 1997;42(7):568-576. doi:10.1016/S06-323(96) 040-4 PubMed (Pubitemid 27425475)
38. Troxel WM, Buysse DJ, Matthews KA, et al. Sleep symptoms predict the development of the metabolic syndrome. Sleep. 2010;33(12):1633-1640.
39. Dew MA, Hoch CC, Buysse DJ, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65(1):63-73. doi:10.1097/01.PSY.039756.23250.7C PubMed (Pubitemid 36143197)
40. Monk TH, Reynolds CF 3rd, Machen MA, et al. Daily social rhythms in the elderly and their relation to objectively recorded sleep. Sleep. 1992;15(4):322-329. PubMed
41. Edinger JD, Fins AI, Glenn DM, et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol. 2000;68(4):586-593. doi:10.1037/02-06X.68.4.586 PubMed
42. Fernandez-Mendoza J, Calhoun SL, Bixler EO, et al. Sleep misperception and chronic insomnia in the general population: role of objective sleep duration and psychological profiles. Psychosom Med. 2011;73(1):88-97. doi:10.1097/PSY.0b013e3181fe365a PubMed
43. Fichten CS, Creti L, Amsel R, et al. Poor sleepers who do not complain of insomnia: myths and realities about psychological and lifestyle characteristics of older good and poor sleepers. J Behav Med. 1995;18(2):189-223. doi:10.107/BF01857869 PubMed
44. Vgontzas AN, Liao D, Pejovic S, et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010;33(9):1159-1164. PubMed
45. Nabi H, Kivimäki M, Suominen S, et al. Does depression predict coronary heart disease and cerebrovascular disease equally well? the Health and Social Support Prospective Cohort Study. Int J Epidemiol. 2010;39(4):1016-1024. doi:10.1093/ije/dyq050 PubMed
46. Stewart RA, North FM, West TM, et al Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Investigators. Depression and cardiovascular morbidity and mortality: cause or consequence? Eur Heart J. 2003;24(22):2027-2037. doi:10.1016/j.ehj.203.08.017 PubMed (Pubitemid 37420450)
47. Vaccarino V, Johnson BD, Sheps DS, et al National Heart, Lung, and Blood Institute. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol. 2007;50(21):2044-2050. doi:10.1016/j.jac.207.07.069 PubMed (Pubitemid 350087570)
48. Dobbels F, De Geest S, Vanhees L, et al. Depression and the heart: a systematic overview of definition, measurement, consequences and treatment of depression in cardiovascular disease. Eur J Cardiovasc Nurs. 2002;1(1):45-55. doi:10.1016/S1474-5151(01)012-3 PubMed (Pubitemid 36842724)
49. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull. 1996;52(3):597-617. PubMed (Pubitemid 26329157)
50. Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychol Bull. 1991;110(3):406-425. doi:10.1037/03-2909.10.3.406 PubMed
51. Shaffery J, Hoffmann R, Armitage R. The neurobiology of depression: perspectives from animal and human sleep studies. Neuroscientist. 2003;9(1):82-98. doi:10.17/107385840239594 PubMed (Pubitemid 36139582)
52. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48(8):830-843. doi:10.1016/S06-323